GENE ONLINE|News &
Opinion
Blog

Drug Development
Asia-Pacific BIO Asia-Taiwan
BIO Asia-Taiwan 2023: New Asian Age
2023-08-10
Trials & Approvals AstraZenca
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
Licensing Sosei Heptares
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
Licensing IONIS-FB-LRx
Roche Receives Rights to Ionis’ Antisense Kidney Disease Drug for $55 Million
2022-07-12
R&D Alzheimer's Disease
Are Memory Loss in Alzheimer’s Disease Related to Changes in Blood Vessels in the Brain?
2022-07-07
Technology Drug Development
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production
2022-06-05Partner
Asia-Pacific AI
Israeli and South Korean Companies Collaborate in Drug Innovation with Data Platform
2022-04-19
Special 2022 psychedelics
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
Innovation Alzheimer's Disease
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
Asia-Pacific
Korea’s First Private-Led New Drug Cluster to Launch in Late September
2021-09-11
VIRTUALMAN Breaking Barriers in Drug Development with AI Solutions
2021-08-05Partner
AI Technology Revamping Drug Development! VIRTUALMAN to Demonstrate Powerful Solutions in BIO Asia-Taiwan 2021
2021-07-15Partner
Funding Drug Development
Genesis Bags $52M Series A to Employ AI for Drug Discovery and Development
2020-12-06
COVID-19 Japan
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Trials & Approvals Anti-HIV
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
1 2
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top